Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,513,111
+$265,371 QoQ
Shares Held
6,013
+4.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#2,164
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Archford Capital Strategies, LLC holds $29,267,302 across 10 Drug Manufacturers - General names. ABBV ranks #5 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
40,636 | $10,320,324 | |
| 2 | NVS |
Novartis AG
|
49,908 | $7,821,581 | |
| 3 | MRK |
Merck & Co., Inc.
|
27,354 | $3,514,989 | |
| 4 | LLY |
ELI LILLY & Co
|
2,586 | $3,101,726 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
6,013 | $1,513,111 | |
| 6 | SNY |
Sanofi
|
33,227 | $1,417,463 | |
| 7 | AZN |
Astrazeneca PLC
|
2,652 | $502,872 | |
| 8 | PFE |
Pfizer Inc
|
18,376 | $442,494 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,513,111 | 6,013 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $1,247,740 | 5,737 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,205,513 | 5,276 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,214,658 | 5,246 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $989,540 | 5,331 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,116,532 | 5,329 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $944,475 | 5,315 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,102,135 | 5,581 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $986,754 | 5,753 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $2,441,414 | 13,407 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,967,034 | 12,693 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,622,219 | 10,883 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,571,355 | 11,663 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,862,875 | 11,689 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,632,261 | 10,100 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $1,167,358 | 8,698 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,335,861 | 8,722 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $1,245,491 | 7,683 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $976,640 | 7,213 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $743,871 | 6,896 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $736,440 | 6,538 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $661,115 | 6,109 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $2,984,984 | 27,858 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $2,438,943 | 27,845 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $2,733,527 | 27,842 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $2,139,491 | 28,081 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||